VIEW MENU
Pet Age
 

Aratana Agrees to Acquire Vet Therapeutics


December 3, 2013

Aratana Therapeutics, a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, entered into a merger agreement providing for the strategic acquisition of Vet Therapeutics, Inc., a San Diego-based company with a proprietary antibody-based biologics platform.

Under the agreement, Aratana plans to continue to advance the pipeline of high value biologic drugs, including its lymphoma franchise. Lymphoma is the most common blood cancer in dogs, accounting for an estimated 6 percent of total dog cancers, the company said.

The acquisition of Vet Therapeutics is expected to significantly accelerate Aratana’s pathway toward becoming a commercial-stage pet therapeutics company.

Share This Story On:

Enews Subscribe

Sign up for Pet Age's Weekly E-newsletter for the latest in pet business news, recalls and more.

Event Calendar

Events Calendar

« April 2017 » loading...
M T W T F S S
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Sun 23

Northwest Grooming Show

April 20 - April 23
Sun 23

Calgary Pet Industry Trade Show

April 22 - April 23
Fri 28
Fri 28

America’s Family Pet Expo

April 28 - April 30
close
Business Webinar Series
View recaps of our latest webinars here. Learn More